发明名称 |
COMPOUNDS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS |
摘要 |
A method for the treatment of systemic lupus erythematosus (SLE) by administering antisense cAMP response element modulator (antisense CREM) to patients with systemic lupus erythematosus. The antisense CREM increases the production Interleukin-2(IL-2) which is decreased in SLE patients. Additionally, this invention relates to taking freshly isolated SLE T cells and transfecting them with TCR zeta chain construct in a eukaryotic expression vector, at high efficiency by a recently developed nucleoporation technique for the restoration of TCR/CD3-mediated signaling in the zeta chain transfected cells. Reconstitution of deficient TCR zeta chain can reverse the TCR/CD3-mediated signaling abnormalities as well as the defective IL-2 production in T cells of SLE patients. |
申请公布号 |
WO2004071418(A3) |
申请公布日期 |
2004.10.28 |
申请号 |
WO2004US03210 |
申请日期 |
2004.02.05 |
申请人 |
WALTER REED ARMY INSTITUTE OF RESEARCH;TSOKOS, GEORGE, C.;JUANG, YUANG-TAUNG |
发明人 |
TSOKOS, GEORGE, C.;JUANG, YUANG-TAUNG |
分类号 |
A61K38/00;A61K48/00;A61P37/00;C12N15/113 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|